Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | FBP1 | P09467 | 4/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
| ▸ | PPID | Q08752 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5793098 | 0.87 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPK1PPARAPPARG | |
| SCHEMBL6081047 | 0.84 | FBP1 (0.52) | L3MBTL1FBP1MMP8PPARAPPARG | |
| SCHEMBL6080934 | 0.81 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1MAPK1FBP1MMP8 | |
| SCHEMBL23241654 | 0.81 | TBXAS1 (0.44) | ALDH1A1L3MBTL1FBP1TBXAS1PPID | |
| SCHEMBL6080648 | 0.81 | CYP1A2 (0.47) | ALDH1A1L3MBTL1MAPK1PPARAPPARG | |
| SCHEMBL31745361 | 0.80 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1MAPK1FBP1MMP8 | |
| SCHEMBL21455371 | 0.80 | TBXAS1 (0.45) | ALDH1A1L3MBTL1FBP1TBXAS1PPID | |
| SCHEMBL6080910 | 0.80 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1MAPK1FBP1MMP8 | |
| SCHEMBL6081371 | 0.80 | PPARA (0.61) | ALDH1A1L3MBTL1MAPK1FBP1MMP8 | |
| SCHEMBL4681650 | 0.79 | FBP1 (0.54) | ALDH1A1FBP1MMP8PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | GENFIT (FR) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | AADAC, NAT1, PARN | ALDH1A1 845/4885L3MBTL1 2320/4885MAPK1 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.